Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554068 · ClinicalTrials.gov registry record · Phase 2
Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
A Phase 2 study of Shingles, sponsored by Loyola University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05554068: Recruiting Phase 2 study of Shingles, sponsored by Loyola University.
NCT05554068 is a Phase 2 study of Shingles that is actively recruiting participants, run by Loyola University. The registered enrollment target is 100 participants, below the 382-participant average among 6 other Shingles trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05554068, a Phase 2 study of Shingles, is actively recruiting participants, sponsored by Loyola University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase II study that will examine the immunogenicity of the Shingrix vaccine in patients following an allogeneic stem cell transplant.
Conditions Studied
Interventions
- DRUG Shingrix
Study Locations (1)
Illinois
- Loyola University Medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-07 |
| Est. Completion | 2026-11-01 |
| Phase | Phase 2 |
What NCT05554068 shows while recruiting
NCT05554068 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 382-participant average among 6 other Shingles trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Shingles appearing as the primary indexed condition, and to 1 intervention - of which Shingrix is the first listed.
NCT05554068 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05554068 about?
NCT05554068 is a clinical study titled "Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients". This is a phase II study that will examine the immunogenicity of the Shingrix vaccine in patients following an allogeneic stem cell transplant.
What is the current status of trial NCT05554068?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2023-03-07. Estimated completion is 2026-11-01.
What conditions does trial NCT05554068 study?
This clinical trial studies the following conditions: Shingles.
What interventions are being tested in trial NCT05554068?
The interventions under investigation include: Shingrix (DRUG).
Who is sponsoring clinical trial NCT05554068?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05554068 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shingles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
ACTIVE NOT RECRUITING · Phase 2
-
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
ACTIVE NOT RECRUITING · Phase 2
-
Systems Biology of Zoster Vaccine
COMPLETED · Phase 2
-
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
COMPLETED · Phase 1
-
Valacyclovir in Immunocompromised Children
COMPLETED · Phase 1
-
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI